arrow
H

Henry Lik‐Yuen Chan

Union Hospital
H-index:112
Citation Count:4.9万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Is Partial Cure a Realistic Endpoint for Novel Hepatitis B Therapy?

部分治愈是新型乙型肝炎治疗的现实终点吗?

2026-01-170
PRE
Evaluation of Factors Influencing Specialist Referral Among Individuals Tested Positive for HBsAg in Health Check Programs in Hong Kong

评估香港健康检查项目中HBsAg检测阳性者接受专科转诊的影响因素

2025-12-010
PRE
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

乙型肝炎病毒再激活在肝癌患者中接受免疫检查点抑制剂或酪氨酸激酶抑制剂治疗时的比较风险

2025-09-050
OAAI
Long-Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver-Related Events in Nucleos(t)ide Analogue-Treated Chronic Hepatitis B Patients in China

中国核苷(酸)类似物治疗的慢性乙型肝炎患者中,丙氨酸氨基转移酶水平的长期动态变化与肝脏相关事件相关。

2025-05-190
PRE
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B

慢性乙型肝炎患者代谢合并症与肝纤维化严重程度及肝纤维化消退的关系。Clin. Gastroenterol. Hepatol, S1542-3565(25)00411-2

2025-05-150
OAAI
A Massively Parallel Reporter Assay Library to Screen Short Synthetic Promoters in Mammalian Cells

大规模并行报告者分析文库,用于筛选哺乳动物细胞中的短合成启动子

2025-03-010
PRE
A massively parallel reporter assay library to screen short synthetic promoters in mammalian cells
2024-11-280
OAAI
Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection

中国慢性乙型肝炎感染患者肝细胞癌监测临床诊断算法的前瞻性评估

2024-11-220
OAAI
Sequential therapy with antisense oligonucleotide and immune modulator as a strategy for HBV cure

序贯疗法:以反义寡核苷酸和免疫调节剂作为HBV治愈策略

2024-10-010
PRE
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
2024-09-272
OAAI
A pilot integrated model nurse clinic increases the uptake of antiviral treatment for the prevention of mother-to-child transmission of HBV
2024-07-051
OAAI
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

有限的持续缓解后核苷 (酸) ide类似物退出: 从慢性乙型肝炎患者的大型,全球性,多种族队列的结果 (RETRACT-B研究)

2024-05-140
PRE
Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
2024-04-0113
PRE
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study) (vol 118, pg 1601, 2023)
2024-03-111
OA
CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
2024-02-291
PRE
Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses
2024-02-260
PRE
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

25个国家和地区丁型肝炎病毒流行率的调整估计

2024-02-0125
OAAI
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

在前瞻性队列研究中检测HCC的新型算法评分 (GAAD) 的开发和临床验证

2023-11-0117
OAAI
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
2023-10-185
OAAI
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
2023-10-018
PRE